ArticleJournal of cardiothoracic surgery2026
Perioperative management of a patient with comorbid immune thrombocytopenia and antiphospholipid syndrome undergoing minimally invasive mitral valve surgery.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough rare, immune thrombocytopenia can coexist with antiphospholipid syndrome, creating a management dilemma between maintaining hemostasis and preventing thromboembolism. Herein, we report our strategic perioperative management of a patient with this complex hematological profile who underwent minimally invasive cardiac surgery. CASE PRESENTATION: A 55-year-old man with chronic atrial fibrillation and severe mitral regurgitation was diagnosed with immune thrombocytopenia and antiphospholipid syndrome. A minimally invasive cardiac surgery approach was chosen to minimize surgical trauma and the risk of perioperative bleeding. The mitral valve exhibited thickened chordae and leaflet retraction accompanied by verrucous excrescences, which are highly suggestive of Libman-Sacks endocarditis. Despite attempts at valve repair using annuloplasty, artificial chordae, and cleft closure, significant mitral regurgitation persisted because of extensive fibrotic changes. Consequently, the procedure was converted to mitral valve replacement with a mechanical prosthesis. Although the patient's platelet count immediately dropped to 12,000/µL postoperatively, prompt treatment with platelet transfusion and high-dose immunoglobulin therapy ensured rapid recovery. The patient was discharged without any complications, even after initiating anticoagulation therapy with warfarin.
conclusionManaging cardiac surgery in patients with comorbid immune thrombocytopenia and antiphospholipid syndrome presents a significant therapeutic challenge. Based on our experience, a minimally invasive approach combined with a strategic perioperative protocol (specifically, postponing immunoglobulin therapy until the immediate postoperative period to facilitate rapid platelet recovery alongside anticoagulation) can achieve successful outcomes while balancing the conflicting risks of thrombosis and hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.